x

Search for a clinical trial

* (*) mandatory field

A Phase 2 open-label, dose-escalation study to evaluate the safety, pharmacokinetics, immunogeniticy and pharmacodynamics/efficacy of EDI200, an EDA-A1 replacement protein, administered to infants with X-Linked Hypohidrotic Ectodermal Dysplasia - DE - Completed

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Terminated trial
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Edimer pharmaceuticals inc.
  • Website
  • Principal investigator of clinical trial

  • Pr Holm SCHNEIDER
  • Abteilung für Molekulare Pädiatrie
  • Kinder- und Jugendklinik des Universitätsklinikums Erlangen
  • Loschgestraße 15
  • 91054 ERLANGEN
  • GERMANY
  • More information
  • Phone  : 49 (0)9131 85 36220
  • Fax  : 49 (0)9131 85 33013
  • Website
  • Contact secretary  :
Last update: March 2017

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.